3-(4-(5-(4-((3-Benzyl-9-methyl-4H,6H-thieno[2,3-e][1,2,4]-triazolo[3,4-c][1,4]oxazepin-2-yl)ethynyl)-1H-pyrazol-1-yl)pent-1-yn-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

ID: ALA4572428

Chembl Id: CHEMBL4572428

PubChem CID: 155564542

Max Phase: Preclinical

Molecular Formula: C39H33N7O4S

Molecular Weight: 695.80

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nnc2n1Cc1sc(C#Cc3cnn(CCCC#Cc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)c3)c(Cc3ccccc3)c1OC2

Standard InChI:  InChI=1S/C39H33N7O4S/c1-25-42-43-35-24-50-37-30(19-26-9-4-2-5-10-26)33(51-34(37)23-45(25)35)16-14-27-20-40-44(21-27)18-7-3-6-11-28-12-8-13-29-31(28)22-46(39(29)49)32-15-17-36(47)41-38(32)48/h2,4-5,8-10,12-13,20-21,32H,3,7,15,17-19,22-24H2,1H3,(H,41,47,48)

Standard InChI Key:  YASDSJZYJJDBIQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4572428

    ---

Associated Targets(Human)

MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RS4-11 (1012 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD3 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 3 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 4 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD2 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 2 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Protein cereblon/Cullin-4A/GSPT1 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 695.80Molecular Weight (Monoisotopic): 695.2315AlogP: 4.37#Rotatable Bonds: 6
Polar Surface Area: 124.24Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.61CX Basic pKa: 2.09CX LogP: 4.40CX LogD: 4.40
Aromatic Rings: 5Heavy Atoms: 51QED Weighted: 0.16Np Likeness Score: -0.57

References

1. Qin C, Hu Y, Zhou B, Fernandez-Salas E, Yang CY, Liu L, McEachern D, Przybranowski S, Wang M, Stuckey J, Meagher J, Bai L, Chen Z, Lin M, Yang J, Ziazadeh DN, Xu F, Hu J, Xiang W, Huang L, Li S, Wen B, Sun D, Wang S..  (2018)  Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression.,  61  (15): [PMID:30019901] [10.1021/acs.jmedchem.8b00506]

Source